Related Experiment Video
Updated: Jul 20, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Hypothalamic-endocrine aspects in Huntington's disease
Asa Petersén1, Maria Björkqvist
1Neuronal Survival Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, BMC A10, 22184 Lund, Sweden. asa.petersen@med.lu.se
Insights
Huntington's disease (HD) involves brain cell death and hypothalamic dysfunction. Investigating neuroendocrine changes may reveal biomarkers for new Huntington's disease therapies.
Area of Science:
- Neuroscience
- Genetics
- Endocrinology
Background:
- Huntington's disease (HD) is a hereditary neurodegenerative disorder caused by CAG triplet repeat expansion in the huntingtin gene.
- Neuropathology in HD includes protein aggregates and neuronal loss in the striatum and cerebral cortex.
- Early HD stages show hypothalamic atrophy, affecting orexin and somatostatin cell populations, potentially explaining symptoms like sleep and weight disturbances.
Purpose of the Study:
- To explore the role of hypothalamic and endocrine system dysfunction in Huntington's disease.
- To investigate neuroendocrine changes as potential biomarkers for HD.
- To identify novel therapeutic targets for Huntington's disease.
Main Methods:
- Review of neuropathological findings in HD, focusing on the hypothalamus.
- Analysis of endocrine changes in HD patients and mouse models.
- Consideration of neuroendocrine factors in cerebrospinal fluid, blood, and urine as potential biomarkers.
Main Results:
- Hypothalamic atrophy and neuronal loss occur early in HD.
- HD patients exhibit endocrine alterations, including elevated cortisol, reduced testosterone, and increased diabetes prevalence.
- HD mouse models show hypothalamic-pituitary-adrenal axis dysfunction and pancreatic beta-cell/adipocyte issues.
Conclusions:
- The hypothalamus and endocrine system are significantly impacted in Huntington's disease.
- Neuroendocrine factors may serve as valuable biomarkers for disease state and therapeutic response in HD.
- Understanding these neuroendocrine changes could lead to novel therapeutic strategies for Huntington's disease.
Abstract:
Huntington's disease (HD) is a hereditary and fatal disorder caused by an expanded CAG triplet repeat in the HD gene, resulting in a mutant form of the protein huntingtin. Wild-type and mutant huntingtin are expressed in most tissues of the body but the normal function of huntingtin is not fully known. In HD, the neuropathology is characterized by intranuclear and cytoplasmic inclusions of huntingtin aggregates, and cell death primarily in striatum and cerebral cortex. However, hypothalamic atrophy occurs at early stages of HD with loss of orexin- and somatostatin-containing cell populations. Several symptoms of HD such as sleep disturbances, alterations in circadian rhythm, and weight loss may be due to hypothalamic dysfunction. Endocrine changes including increased cortisol levels, reduced testosterone levels and increased prevalence of diabetes are found in HD patients. In HD mice, alterations in the hypothalamic-pituitary-adrenal axis occurs as well as pancreatic beta-cell and adipocyte dysfunction. Increasing evidence points towards important pathology of the hypothalamus and the endocrine system in HD. As many neuroendocrine factors are secreted into the cerebrospinal fluid, blood and urine, it is possible that their levels may reflect the disease state in the central nervous system. Investigating neuroendocrine changes in HD opens up the possibility of finding biomarkers to evaluate future therapies for HD, as well as of identifying novel targets for therapeutic interventions.
More Related Videos
09:29Isolation of Targeted Hypothalamic Neurons for Studies of Hormonal, Metabolic, and Electrical Regulation
Published on: August 4, 2023
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Related Concept Videos
Huntington Disease l: Introduction
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Cushing Syndrome II: Pathophysiology
Regulation of Hormone Secretion
Humoral stimuli,...
Hypothyroidism II: Pathophysiology
Diencephalon: Hypothalamus and Coordination
The hypothalamus interacts with other brain regions, including the pituitary gland, through a direct physical connection called the hypothalamic-pituitary axis. The hypothalamus receives somatic and visceral inputs and...